Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹1,474 Cr
Revenue (TTM)
₹810 Cr
Net Profit (TTM)
₹84 Cr
ROE
8.9 %
ROCE
12.2 %
P/E Ratio
17.5
P/B Ratio
1.4
Industry P/E
38.52
EV/EBITDA
8.2
Div. Yield
0.4 %
Debt to Equity
0
Book Value
₹99.6
EPS
₹8
Face value
1
Shares outstanding
105,445,522
CFO
₹930.53 Cr
EBITDA
₹1,431.27 Cr
Net Profit
₹840.21 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Bliss GVS Pharma
| -15.2 | 16.0 | 24.2 | 31.9 | 23.6 | 7.0 | 1.6 |
|
BSE Healthcare
| -4.5 | 1.7 | 8.6 | 15.7 | 27.1 | 21.7 | 10.5 |
|
BSE Small Cap
| -3.2 | 3.9 | 21.0 | 3.6 | 30.0 | 34.8 | 17.3 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Bliss GVS Pharma
| 31.9 | 72.2 | -30.2 | -48.8 | 36.7 | -7.5 | -22.7 |
|
BSE Small Cap
| 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 | -23.4 |
|
BSE Healthcare
| 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 | -5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Bliss GVS Pharma
|
139.6 | 1,474.1 | 809.7 | 90.3 | 12.0 | 8.2 | 17.5 | 1.4 |
| 718.4 | 2,072.0 | 451.8 | 50.8 | 11.4 | 16.3 | 40.8 | 6.3 | |
| 468.4 | 7,638.2 | 2,108.1 | 266.8 | 12.5 | 11.7 | 28.6 | 3.3 | |
| 363.2 | 3,636.1 | 819.8 | 69.7 | 13.9 | 11.9 | 52.2 | 6.0 | |
| 428.8 | 2,621.5 | 559.1 | -8.7 | -10.9 | -159 | -- | 3.1 | |
| 5,951.0 | 9,886.6 | 1,218.1 | 251.2 | 28.1 | -- | 39.4 | 18.4 | |
| 917.9 | 8,994.8 | 1,286.4 | 79.6 | 15.9 | 4.7 | 114.9 | 3.8 | |
| 853.8 | 7,873.5 | 4,632.7 | 358.2 | 14.8 | 15 | 2.2 | 3.1 | |
| 670.9 | 5,392.8 | 696.5 | 188.0 | 34.5 | 19.8 | 28.7 | 5.4 | |
| 19.3 | 1,817.0 | 466.0 | 49.4 | 10.7 | 15.1 | 36.8 | 5.3 |
No Review & Analysis are available.
Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear... drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, it offers therapeutic products consisting of anti-bacterial, anti-dandruff shampoo, amino acid preparation, iron tonic, antitussive, appetite stimulant, anti-allergic, body supplement, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, ear wax solvent, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, oral rehydration, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as soaps. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India. Read more
Incorporated
1984
Chairman
S R Vaidya
Managing Director
Gagan Harsh Sharma
Headquarters
Mumbai, Maharashtra
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Bliss GVS Pharma Ltd stood at ₹ 1,301 Cr as on 31-Mar-25
The share price of Bliss GVS Pharma Ltd is ₹139.64 (NSE) and ₹139.80 (BSE) as of 18-Jun-2025 IST. Bliss GVS Pharma Ltd has given a return of 23.6% in the last 3 years.
Bliss GVS Pharma Ltd has a market capitalisation of ₹ 1,474 Cr as on 18-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Bliss GVS Pharma Ltd is 1.40 times as on 18-Jun-2025, a 74% discount to its peers’ median range of 5.48 times.
The P/E ratio of Bliss GVS Pharma Ltd is 17.49 times as on 18-Jun-2025, a 55% discount to its peers’ median range of 38.52 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Bliss GVS Pharma Ltd and enter the required number of quantities and click on buy to purchase the shares of Bliss GVS Pharma Ltd.
Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, it offers therapeutic products consisting of anti-bacterial, anti-dandruff shampoo, amino acid preparation, iron tonic, antitussive, appetite stimulant, anti-allergic, body supplement, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, ear wax solvent, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, oral rehydration, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as soaps. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.
The promoter of Bliss GVS Pharma Ltd is Narsimha Shibroor Kamath. Narsimha Shibroor Kamath owns 30.78 per cent of the total equity. The chairman of the company is S R Vaidya , and the managing director is Gagan Harsh Sharma..
There is no promoter pledging in Bliss GVS Pharma Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
9,692
|
|
|
9,644
|
|
|
8,142
|
|
|
7,752
|
|
|
5,552
|
|
|
3,729
|
|
|
2,767
|
|
|
2,021
|
|
|
2,017
|
| Bliss GVS Pharma Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
8.18
|
|
Operating margin(%)
|
12.01
|
|
Net Margin(%)
|
10.67
|
|
Dividend yield(%)
|
0.36
|
Yes, TTM profit after tax of Bliss GVS Pharma Ltd was ₹84 Cr.
₹-2.20
(
